Focused Ultrasound Personalized Therapy for the Treatment of Depression (UPSIDE)

The UPSIDE project aims to develop a minimally invasive hybrid neurotechnology for targeted brain stimulation and biomarker monitoring to enhance treatment for Treatment-Resistant Depression.

Subsidie
€ 4.149.921
2022

Projectdetails

Introduction

Major depressive disorder (MDD) is the leading cause of disability worldwide, affecting 300 million people with a lifetime prevalence of 15%. Approximately one third of all MDD patients fail to respond to currently established treatments based on medication and psychotherapy, thus falling into the category of Treatment-Resistant Depression (TRD) patients.

Current Treatment Limitations

Electroconvulsive therapy (ECT), repetitive Transcranial Magnetic Stimulation (tRMS), Vagus nerve stimulation (VNS), deep brain stimulation (DBS), and transcranial focused ultrasound (tFUS) still show:

  • Poor spatial resolution (ECT, tRMS, tFUS)
  • Low network coverage (VNS, DBS)

With average remission rates in clinical trials still lower than 30%.

Need for Biomarkers

Apart from the existing stimulation hurdles, reliable biomarkers for depression are needed as a diagnostic tool. In the case of neurotechnology (NT), these biomarkers can help determine stimulation efficacy and allow for personalized treatment.

Project Overview

The UPSIDE project proposes a minimally invasive, high spatial resolution, and multi-brain region stimulation and recording system to largely exceed the capabilities of existing NT for depression.

Objectives

Our objective is to research and validate in vivo a hybrid neurotechnology consisting of:

  1. An epidural focused ultrasound (eFUS) stimulator employing three-dimensional beamforming
  2. A high-density epidural EEG recording system

Technological Innovations

Epidural deployment of these devices will be enabled by novel methods for:

  • Massive integration and miniaturization of high-performing piezoelectric ultrasound materials
  • High-fidelity organic bioelectronic materials
  • High energy-efficient complementary metal-oxide semiconductor (CMOS) technology in a biocompatible manner

Expected Outcomes

The UPSIDE project will result in a demonstrator which will allow, for the first time, network stimulation and simultaneous biomarker readout in behavioral experiments with animal models featuring depression-like symptoms.

This technological breakthrough will pave the way towards a personalized treatment for TRD.

Financiële details & Tijdlijn

Financiële details

Subsidiebedrag€ 4.149.921
Totale projectbegroting€ 4.149.921

Tijdlijn

Startdatum1-9-2022
Einddatum31-8-2026
Subsidiejaar2022

Partners & Locaties

Projectpartners

  • TECHNISCHE UNIVERSITEIT DELFTpenvoerder
  • UNIVERSITEIT GENT
  • UNIVERSITAETSKLINIKUM FREIBURG
  • NEWRONIKA SPA
  • SILICONGATE LDA
  • Micro Systems Technologies Management GmbH
  • FOCUSED ULTRASOUND FOUNDATION

Land(en)

NetherlandsBelgiumGermanyItalyPortugalUnited States

Vergelijkbare projecten binnen EIC Pathfinder

EIC Pathfinder

A multiplexed biomimetic imaging platform for assessing single cell plasticity (Plastomics) and scoring of tumour malignancy

The PLAST_CELL project aims to develop a microfluidics-based imaging platform to quantify cancer cell plasticity, enhancing diagnosis and treatment of metastasis and therapy resistance.

€ 2.982.792
EIC Pathfinder

"Creation of innovative ""humidity to electricity"" renewable energy conversion technology towards sustainable energy challenge"

The CATCHER project aims to develop scalable technology for converting atmospheric humidity into renewable electricity, enhancing EU leadership in clean energy innovation.

€ 2.996.550
EIC Pathfinder

Smart Electronic Olfaction for Body Odor Diagnostics

SMELLODI aims to digitize and synthesize olfactory information for remote disease diagnostics and assist individuals with olfactory disorders using advanced sensor technology and machine learning.

€ 3.263.781
EIC Pathfinder

Quantitative Ultrasound Stochastic Tomography - Revolutionizing breast cancer diagnosis and screening with supercomputing-based radiation-free imaging.

The project aims to revolutionize breast cancer imaging by developing adjoint-based algorithms for uncertainty quantification, enhancing diagnostic confidence through high-resolution, radiation-free images.

€ 2.744.300

Vergelijkbare projecten uit andere regelingen

ERC POC

Deep Brain Neuromodulation using Temporal Interference Magnetic Stimulation

Develop a non-invasive tool using temporal interference magnetic stimulation for precise modulation of neural activity in the brain, aiming to improve treatment options for brain disorders.

€ 150.000
ERC COG

Bidirectional Brain/Neural-Computer Interaction for Restoration of Mental Health

This project aims to develop a portable neuromodulation system using quantum sensors and magnetic stimulation to precisely target brain oscillations for treating mental health disorders.

€ 1.999.875
ERC STG

Dissecting the biophysical mechanisms of deep brain stimulation using voltage fluorescence microscopy

This project aims to elucidate the cellular mechanisms of deep brain stimulation in epilepsy using a novel optical technique to improve therapeutic protocols for human patients.

€ 1.498.729
ERC STG

Minimally invasive and closed-loop ultrasound neuromodulation and recording for the treatment of focal epilepsy

This project aims to develop a minimally invasive, closed-loop ultrasound neuromodulation system for treating refractory epilepsy, optimizing protocols through a comprehensive computational framework.

€ 1.499.575